Respiratory
-
High mortality and financial burden for NTM
The high costs of a lung disease caused by organisms in soil and water has been revealed for the first time in a European study. Read more
-
DNA test to warn of lung cancer recurrence
Oncologists may soon be able to test for unstable chromosomes to identify lung cancer patients with high risk of disease recurrence, British researchers reported last night. Read more
-
Question over steroids for sore throat
British researchers have cast doubt on the role of oral dexamethasone in the treatment of adults with a sore throat. Read more
-
College concern on indoor air pollution
Two medical royal colleges have joined a new drive to investigate the health impact of indoor air pollution in homes. Read more
-
Antibody removal treats chronic lung disease
A treatment that removes antibodies from the blood can improve the care of patients with chronic infection, British researchers report today. Read more
-
Stem cell lung disease hope
Stem cell therapy is showing promise as a potential treatment for some chronic inflammatory lung diseases, a European conference has heard. Read more
-
Guidance call for new TB drugs
New antibiotics could help stem the spread of multi-drug resistant TB – but clinicians need clear guidelines on their use to ensure they remain effective, experts say today in a report marking World TB Day. Read more
-
How air pollution boosts bacterial disease
Disease-causing bacteria are directly affected by air pollution, which can increase their resistance to drugs, British researchers reported today. Read more
-
Study backs vitamin D to prevent infection
Low levels of vitamin D may help explain the spread of colds and flu during the winter, according to a major international research project published today. Read more
-
Extended therapy needed for hay fever
It takes three years of treatment with grass pollen immunotherapy to achieve extended reduction of symptoms of allergic rhinitis, researchers reported last night. Read more